-
Listing
Strengthening Europe’s strategic autonomy through capital marketsCzechoslovak Group lists on EuronextLees meerWorld’s largest defence IPO ever recorded.
Learn more about Euronext’s initiatives to enhance financing and visibility for European aerospace and defence companies -
Handelsinformatie
Where European Government Bonds meet the futureFixed Income derivativesLees meerTrade Mini Bond Futures on main European Government Bonds
-
Clearing
Step into Europe’s next phase of Repo ClearingRepo ClearingLees meerEuronext is expanding its repo clearing services to boost market access, liquidity provision and collateral optimisation across Europe.
-
CSD
European CSD modelBuilding the CSD of Choice in EuropeLees meerEuronext Securities is shaping the future of European capital markets by enhancing integration, connectivity, and innovation.
-
Technology
Euronext Technology SolutionsHigh-Frequency Trading Solution (HFTS)Lees meerThe new generation of high-frequency risk trading platforms, offering the highest performance with ultra-low latency and minimal jitter, all at a low total cost of ownership.
-
Data
-
Indices
Access the white paperInvesting in the future of Europe with innovative indicesLees meerThe first edition of the Euronext Index Outlook series with a particular focus on the European Strategic Autonomy Index.
- Reglementen
-
About Euronext
Euronext strategic planInnovate for Growth 2027Lees meerShaping capital markets for future generations
-
Listing
Strengthening Europe’s strategic autonomy through capital marketsCzechoslovak Group lists on EuronextLees meerWorld’s largest defence IPO ever recorded.
Learn more about Euronext’s initiatives to enhance financing and visibility for European aerospace and defence companies -
Handelsinformatie
Where European Government Bonds meet the futureFixed Income derivativesLees meerTrade Mini Bond Futures on main European Government Bonds
-
Clearing
Step into Europe’s next phase of Repo ClearingRepo ClearingLees meerEuronext is expanding its repo clearing services to boost market access, liquidity provision and collateral optimisation across Europe.
-
CSD
European CSD modelBuilding the CSD of Choice in EuropeLees meerEuronext Securities is shaping the future of European capital markets by enhancing integration, connectivity, and innovation.
-
Technology
Euronext Technology SolutionsHigh-Frequency Trading Solution (HFTS)Lees meerThe new generation of high-frequency risk trading platforms, offering the highest performance with ultra-low latency and minimal jitter, all at a low total cost of ownership.
-
Data
-
Indices
Access the white paperInvesting in the future of Europe with innovative indicesLees meerThe first edition of the Euronext Index Outlook series with a particular focus on the European Strategic Autonomy Index.
- Reglementen
-
About Euronext
Euronext strategic planInnovate for Growth 2027Lees meerShaping capital markets for future generations
- Home
- About
- Media centre
- Bell en Gong Archief
- Pharming Group
Pharming Group
Pharming Group opent handelsdag
Sijmen de Vries, CEO van de op Euronext genoteerde Pharming Group (ticker symbol: PHARM) luidt de gong op de Amsterdamse beurs. Pharming Group viert zijn eerste halfjaar van netto winstgevendheid en de opening van zijn regionale non-deal retail investor roadshow.
Het bedrijf is nu het eerste en enige Nederlandse biotechbedrijf dat een zelf ontwikkeld product, RUCONEST®, in Noord-Amerika commercialiseert. Dit als gevolg van een overeenkomst met haar Amerikaanse partner Valeant Pharmaceuticals om de marketingrechten van haar eigen geneesmiddelen in de VS, Canada en Mexico terug te kopen. Na een wijziging van de overeenkomst met haar EU-partner Sobi, neemt Pharming ook de commercialisering van RUCONEST in het grootste deel van West-Europa op zich.
Voor meer informatie: www.pharming.com